Generic Drugmakers, Activists Praise Lamy; Gurry Defends ‘Respect’ For IP
By William New Generic pharmaceutical producers have grown in importance in recent years despite or because of intellectual property rights, and at their annual meeting this week in Geneva they attracted the leaders of the primary intergovernmental institutions engaged in…
